| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 28.6% | 2/7 |
| Female | 71.4% | 5/7 |
| Indifferent | 0% | 0/7 |
| Unknown | 0% | 0/7 |
| General | ||
| 28.6% | 2/7 | |
| 42.9% | 3/7 | |
| 57.1% | 4/7 | |
| 57.1% | 4/7 | |
| 71.4% | 5/7 | |
| 85.7% | 6/7 | |
| 85.7% | 6/7 | |
| 71.4% | 5/7 | |
| 42.9% | 3/7 | |
| 66.7% | 2/3 | |
| Neurology | ||
| 57.1% | 4/7 | |
| 28.6% | 2/7 | |
| 100% | 7/7 | |
| Facial abnormalities | ||
| 14.3% | 1/7 | |
| 57.1% | 4/7 | |
| 57.1% | 4/7 | |
| 28.6% | 2/7 | |
| Visual and hearing impairments | ||
| Abnormal hearing | 0% | 0/7 |
| 14.3% | 1/7 | |
| Heart | ||
| 14.3% | 1/7 | |
| Pulmonary | ||
| 14.3% | 1/7 | |
| Gastrointestinal | ||
| Gastrointestinal | 0% | 0/7 |
| Urogenital | ||
| 42.9% | 3/7 | |
| Skeleton | ||
| 85.7% | 6/7 | |
| Skin / Hair / Nails | ||
| 71.4% | 5/7 | |
| Endocrine / Immunological / Metabolic | ||
| 14.3% | 1/7 | |
| 14.3% | 1/7 | |
| Immune | 0% | 0/7 |
| Neoplasia | ||
| Neoplasia | 0% | 0/7 |
| Inheritance | ||
| 100% | 7/7 | |
ANKLE2